Current Illinois CancerCare Clinical Trials

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

Study Number: 64091742PCR0002

Study Summary:
The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported DNA-repair gene defects to assess biomarker eligibility for niraparib interventional studies.

Status: Open

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621 cgeoffroy@illinoiscancercare.com
  • Jennifer, 309-243-3617, jboland@illinoiscancercare.com

Study Link

« Search Again